These results suggest that a low cerebral glucose metabolic rate is linked to higher cerebral glucose concentrations and reduced brain insulin sensitivity, contributing to Alzheimer’s disease pathologies in humans [59]. This evidence concerns the gene INS and Alzheimer disease.